NDA Partners Named as One of The Top Ten Medical Device Consulting Companies in 2019 by MedTech Outlook
NDA Partners Chief Executive Officer Earle Martin announced today that the company has been named as one of the Top Ten Medical Device Consulting Companies - 2019 by MedTech Outlook.
ROCHELLE, Va., Aug. 29, 2019 /PRNewswire-PRWeb/ -- NDA Partners Chief Executive Officer Earle Martin announced today that the company has been named as one of the Top Ten Medical Device Consulting Companies – 2019 by MedTech Outlook.
MedTech Outlook recognizes medical device consulting companies that are at the forefront of tackling customer challenges by streamlining business and enabling medical device manufacturers to create the best possible devices while meeting the necessary regulatory requirements. NDA Partners was recognized in this year's awards for providing specialized expertise at the right time to clients through its core group of more than 100 top-tier Expert Consultants, who are some of the most well-known and well-respected professionals in the industry, and for playing a strategic role in turning clients' creative development ideas into marketed medical devices, while ensuring compliance with the complex array of laws and regulations in both the US and globally.
"We are honored to receive this award recognizing NDA Partners as a top medical device consulting company and are strongly committed to providing our clients with exceptional product development planning and program management services," said Dr. David Feigal.
NDA Partners distinguishes itself from other consultancies through its ability to assign top-tier Expert Consultants on all engagements, its ability to provide the full spectrum of functional expertise needed to conduct complete product development programs from bench to marketing authorization, and its leadership in working with early-stage biopharma and medical device development companies. The company has developed a unique and powerful capability for partnering with inventors, discoverers, and owners of intellectual property and early-stage biopharma and medical device companies as a contract development organization (CDO). For these clients, NDA Partners forms world-class product development teams that design, plan, and manage their product development programs.
About MedTech Outlook
MedTech Outlook is a print magazine that covers the most important and latest developments in the healthcare industry. Medical Tech Outlook magazine is a unique learn-from-peer approach where decision makers and experts share valuable views and insights about medical technologies which have had an impact on providing healthcare today.
About NDA Partners
NDA Partners is a life sciences management consulting and CDO focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners(dot)com
SOURCE NDA Partners
Share this article